Matthew Feinsod

CIK 1716950 · Chief Medical Officer · last filed 2026-03-20

Matthew Feinsod is a Chief Medical Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for KLRS, was dated Mar 20, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

31

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRS Chief Medical Officer $4.33 $0 2 2026-03-20
Kalaris Therapeutics, Inc. (ALVR) Delisted Chief Medical Officer 4,030 $9.81 $39.5K $0 1 2025-03-18
APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Exec. VP, Global Strat. & Dev. 56,052 $0.39 $22.1K $0 28 2019-07-31

Recent Filings

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-20 KLRS Grant (A) $0 EDGAR
2025-04-11 KLRS Grant (A) $0 EDGAR
2025-03-18 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) +4,030 $0 EDGAR
2019-07-31 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Grant (A) $0 EDGAR
2019-07-15 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Mixed +1,408 -$2.2K EDGAR
2019-06-20 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Tax (F) −685 -$2.5K EDGAR
2019-06-13 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Mixed +1,315 -$2.6K EDGAR
2019-05-20 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Tax (F) −685 -$2.8K EDGAR
2019-05-15 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Mixed +1,315 -$2.9K EDGAR
2019-04-15 APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Mixed +1,394 -$2.8K EDGAR
Showing 110 of 31
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.